Globalpharma is a wholly owned subsidiary of Dubai Investments. Established in 1998, Globalpharma is currently a market leader in generic pharma segments with a strong regional footprint. started its operations in the UAE in 2003 and expanded its growth in 2008 with product line extensions and new launches across 14 countries in GCC and select African markets. has two Manufacturing plants, A state of art Beta-Lactam Penicillin Manufacturing plant providing the Amoxicillin & AmoxiClav brands in the larger MENA region. Additionally, catering to Lifestyle disease segments, is a General Medicine Plant with a variety of Liquid & Oral Solid Dose.
